MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing
J15 · Effective Apr 17, 2022
11 active Medicare policies list B99.9, and 9 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J15 · Effective Apr 17, 2022
JE · Effective Apr 17, 2022
JF · Effective Apr 17, 2022
JJ · Effective Apr 17, 2022
JM · Effective Apr 17, 2022
J5 · Effective Apr 17, 2022
J8 · Effective Apr 17, 2022
National · Effective Mar 19, 2026
9 policies from 1 payer
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of B99.9 |
|---|---|---|
| Adoptive Immunotherapy and Cellular Therapy | Sep 13, 2023 | Covered |
| Aldesleukin (Proleukin) | Sep 21, 2023 | Covered |
| Deep Brain Stimulation | Apr 11, 2023 | Covered |
| Grenz Ray Therapy for Skin Disorders | Mar 29, 2023 | Covered |
| Heart Transplantation | Aug 30, 2023 | Covered |
| Infusion Pumps | Jan 9, 2024 | Covered |
National · Effective Mar 19, 2026
National · Effective Apr 16, 2026
J5 · Effective Mar 12, 2026
| Oct 6, 2023 |
| Covered |
| Knee Arthroplasty | Nov 20, 2023 | Covered |
|---|
| Pancreas Kidney Transplantation | Aug 30, 2023 | Covered |
|---|